Microalbuminuria and Heart Rate Variability in Adolescents With Diabetes

Journal of Pediatric Health Care

Volumn 24, Issue 1, 2010, Pages 34-41

  Faulkner, Melissa Spezia ^a   Quinn, Lauretta ^a   Fritschi, Cynthia ^a  

^a NONE

Author keywords

adolescents; complications; Diabetes type 1; diabetes type 2

Indexed keywords

CREATININE; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ALBUMINURIA; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MASS SCREENING; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST; NURSE PRACTITIONER; NURSING ASSESSMENT; OBESITY; PEDIATRIC NURSING; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ALBUMINURIA; ARRHYTHMIAS, CARDIAC; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; MASS SCREENING; NURSE PRACTITIONERS; NURSING ASSESSMENT; OBESITY; PEDIATRIC NURSING; RISK ASSESSMENT; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 72049095590     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedhc.2009.01.002     Document Type: Article

References (31)

1. American Diabetes Association. (2008a). Economic costs of diabetes in the U.S. in 2007. Diabetes Care, 31, 596-615.
2. American Diabetes Association. (2008b). Standards of medical care in diabetes-2008. Diabetes Care, 31(Suppl 1), S12-S54.
3. Boysen A., Lewin M.A., Hecker W., Leichter H.E., and Uhlemann F. Autonomic function testing in children and adolescents with diabetes mellitus. Pediatric Diabetes 8 (2007) 261-264
4. Cowan M.J. Measurement of heart rate variability. Western Journal of Nursing Research 17 (1995) 32-48 discussion 101-111
5. Coyer S.M., and Gallo A.M. Secondary analysis of data. Journal of Pediatric Health Care 19 (2005) 60-63
6. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329 (1993) 977-986
7. Donaghue K.C., Chiarelli F., Trotta D., Allgrove J., and Dahl-Jorgensen K. ISPAD clinical practice consensus guidelines 2006-2007. Microvascular and macrovascular complications. Pediatric Diabetes 8 (2007) 163-170
8. Dost A., Klinkert C., Kapellen T., Lemmer A., Naeke A., Grabert M., et al. Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with T1DM. Diabetes Care 31 (2008) 720-725
9. Ewing D.J., Campbell I.W., and Clarke B.F. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Annals of Internal Medicine 92 2 Pt 2 (1980) 308-311
10. Ewing D.J., Neilson J.M., and Travis P. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms. British Heart Journal 52 (1984) 396-402
11. Faulkner M.S., Hathaway D.K., Milstead E.J., and Burghen G.A. Heart rate variability in adolescents and adults with T1DM. Nursing Research 50 (2001) 95-104
12. Faulkner M.S., Quinn L., Rimmer J.H., and Rich B.H. Cardiovascular endurance and heart rate variability in adolescents with type 1 or type 2 diabetes. Biological Research for Nursing 7 (2005) 16-29
13. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18 (1972) 499-502
14. Garg J.P., and Bakris G.L. Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease. Vascular Medicine 7 (2002) 35-43
15. Gerritsen J., Dekker J.M., TenVoorde B.J., Bertelsmann F.W., Kostense P.J., Stehouwer C.D., et al. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 43 (2000) 561-570
16. Kleiger R.E., Miller J.P., Bigger Jr. J.T., and Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. American Journal of Cardiology 59 (1987) 256-262
17. Lambers Heerspink H.J., Brinkman J.W., Bakker S.J., Gansevoort R.T., and de Zeeuw D. Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Current Opinions in Nephrology & Hypertension 15 (2006) 631-636
18. Lane J.T., Ford T.C., Larson L.R., Chambers W.A., and Lane P.H. Acute effects of different intensities of exercise in normoalbuminuric/normotensive patients with T1DM. Diabetes Care 27 (2004) 28-32
19. Lewis E.J., Hunsicker L.G., Bain R.P., and Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. New England Journal of Medicine 329 (1993) 1456-1462
20. Liese A.D., D'Agostino Jr. R.B., Hamman R.F., Kilgo P.D., Lawrence J.M., Liu L.L., et al. The burden of diabetes mellitus among US youth: Prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 118 (2006) 1510-1518
21. Maahs D.M., Snively B.M., Bell R.A., Dolan L., Hirsch I., Imperatore G., et al. Higher prevalence of elevated albumin excretion in youth with type 2 than T1DM: The SEARCH for Diabetes in Youth study. Diabetes Care 30 (2007) 2593-2598
22. Mayer-Davis E.J. T2DM in youth: Epidemiology and current research toward prevention and treatment. Journal of the American Dietetic Association 108 4 Suppl 1 (2008) S45-S51
23. McCrindle B.W., Urbina E.M., Dennison B.A., Jacobson M.S., Steinberger J., Rocchini A.P., Hayman L.L., and Daniels S.R. Drug therapy of high-risk lipid abnormalities in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 115 (2007) 1948-1967
24. McVean J.J.F., Eickhoff J.C., and McDonald M.J. Prevalence of early microalbuminuria in children with type 1 diabetes mellitus. Journal of Pediatric Endocrinology & Metabolism 21 (2008) 469-471
25. Narayan K.M., Boyle J.P., Thompson T.J., Sorensen S.W., and Williamson D.F. Lifetime risk for diabetes mellitus in the United States. JAMA 290 (2003) 1884-1890
26. Paterson A.D., Rutledge B.N., Cleary P.A., Lachin J.M., and Crow R.S. The effect of intensive diabetes treatment on resting heart rate in T1DM: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care 30 (2007) 2107-2112
27. Perkins B.A., Ficociello L.H., Ostrander B.E., Silva K.H., Weinberg J., Warram J.H., et al. Microalbuminuria and the risk for early progressive renal function decline in T1DM. Journal of the American Society of Nephrology 18 (2007) 1353-1361
28. Raile K., Galler A., Hofer S., Herbst A., Dunstheimer D., Busch P., et al. Diabetic nephropathy in 27,805 children, adolescents, and adults with T1DM: Effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 30 (2007) 2523-2528
29. Soltesz G., Patterson C.C., and Dahlquist G. Worldwide childhood T1DM incidence-what can we learn from epidemiology?. Pediatric Diabetes 8 Suppl 6 (2007) 6-14
30. Writing Group D.E. Sustained effect of intensive treatment of T1DM mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290 (2003) 2159-2167
31. Zandbergen A.A., Vogt L., de Zeeuw D., Lamberts S.W., Ouwendijk R.J., Baggen M.G., et al. Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with T2DM and microalbuminuria. Diabetes Care 30 (2007) 3119-3121